请输入您要查询的百科知识:

 

词条 Alvimedica
释义

  1. References

  2. External links

{{Orphan|date=December 2010}}{{Infobox company |
  name   = Alvimedica |  type   = Private|  logo   = |   foundation     = 2007|  location       = Istanbul, Turkey|  key_people     = 
Vedat Alaton, CEO| industry = Medical Instruments & Supplies| products = Medical devices| num_employees = 187 (2009)| homepage = www.alvimedica.com|

}}

Alvimedica is a manufacturer of coronary stents, balloon catheters, diagnostic and guiding catheters. The company was founded in 2007 by Turkish businessmen and scientists living in Denmark and Sweden. The major intention of the company is investing in small and medium size medical device manufacturers to enable them to compete globally. The company made its first investment move by purchasing a medical device company called Nemed in Turkey in 2007. Following this, the company purchased an American company called In-Vivo, a manufacturer of angioplasty and angiography catheters, and one of the suppliers of Abbott Laboratories.

Alvimedica has one of the biggest Class 10.000 cleanrooms of Europe.[1] An area of 700 m² - which also complies with GMP (Good Manufacturing Practice)'s standards - contains the main assembly of catheter and stent systems, including the first drug-eluting stent developed and manufactured in Turkey: Coracto.[2] While Prof. Nicolaus Reifart of the Main-Taunus-Privatklinik in Germany performed the clinical studies, CVPath's well-known Cardiac Pathologist Prof. Renu Virmani conducted animal studies on Coracto SDS (Stent Delivery System) and announced the results at EuroPCR 2009.[3] The study conducted by Dr. Virmani used confocal, scanning electron and light microscopy to examine reendothelialization and inflammation at 14 and 28 days of Coracto, a rapamycin-eluting stent, versus, a sirolimus-eluting stent (SES) and an everolimus-eluting stent (EES) and a bare metal stent (Constant) as a control in a healthy rabbit iliac model. The trial was not powered for significance, but results show that endothelial coverage of Coracto at 14 days was better than that of both EES and SES. As expected, the bare metal stent showed greatest endothelial coverage.[4]

Alvimedica also develops projects in collaboration with universities in Turkey such as Bosphorus University, Istanbul University, Sabanci University, Bilkent University, Yildiz Technical University, Yeditepe University, and international universities like Drexel University (USA), Medical University of Vienna (Austria), and as well as institutions like TASSA (Turkish American Scientists and Scholars Association),[5] CVPath International Registry of Pathology (USA), or the Main-Taunus-Private Clinic (Germany). Alvimedica works with Stent for Life [6] to provide staff training.

In collaboration with TSC (Turkish Society of Cardiology), the company established Turkey's first cardiology simulation center.[7] Together they provide training for Turkish cardiologists as part of an international project called Stent For Life.[8] Through the training sessions the partnership aims at the early detecting of heart attacks and then making sure that the patient will receive the necessary treatment within an hour.[9]

Alvimedica’s headquarters are a 5.500 m² facility located at the free trade zone in Catalca, Istanbul, Turkey. Current projects include amongst others renal and cranial intravascular stents. The company is also working on bio-degradable stents which completely dissolve in the vessel.

Alvimedica sponsored a team for the 2014–2015 Volvo Ocean Race, round-the-world sailing race.

References

1. ^http://cleanroom.net/?p=1413
2. ^http://www.radikal.com.tr/Radikal.aspx?aType=RadikalHaberDetay&Date=&ArticleID=967832
3. ^{{Cite web |url=http://www.alvimedica.com/main.php?pid=18&cid=3 |title=Archived copy |access-date=2010-03-30 |archive-url=https://web.archive.org/web/20100307112215/http://www.alvimedica.com/main.php?pid=18&cid=3 |archive-date=2010-03-07 |dead-url=yes |df= }}
4. ^{{Cite web |url=http://acc10.acc.org/Pages/ACC2010Home.aspx |title=Archived copy |access-date=2010-03-30 |archive-url=https://web.archive.org/web/20100327182940/http://acc10.acc.org/Pages/ACC2010Home.aspx |archive-date=2010-03-27 |dead-url=yes |df= }}
5. ^http://www.todayszaman.com/tz-web/news-196164-106-turkey-eyes-boom-in-medical-investments-with-new-project.html{{Dead link|date=October 2018 |bot=InternetArchiveBot |fix-attempted=yes }}
6. ^http://www.stentforlife.com/
7. ^http://www.tkd.org.tr/pages.asp?pg=421
8. ^{{Cite web |url=http://www.escardio.org/membership/national-societies/news/Pages/Spotlight-Congress-Turkish-Society.aspx |title=Archived copy |access-date=2010-03-30 |archive-url=https://web.archive.org/web/20110726041008/http://www.escardio.org/membership/national-societies/news/Pages/Spotlight-Congress-Turkish-Society.aspx |archive-date=2011-07-26 |dead-url=yes |df= }}
9. ^http://www.europcronline.com/stentforlife/_objectives.php{{Dead link|date=October 2018 |bot=InternetArchiveBot |fix-attempted=yes }}

External links

  • [https://archive.today/20130116161359/http://www.alvimedica.com/index.php?lang=en/ Alvimedica APS, website]
  • [https://web.archive.org/web/20120229102117/http://www.sabanciuniv.edu/ok/eng/?duyurular%2Fdetay.php%3Fno=32108 Sabanci University's Students Visited Alvimedica's HQs]
  • [https://web.archive.org/web/20110722172339/http://www.johnkrause.me/2009/10/06/alvimedica-has-europe%E2%80%99s-largest-10000-class-cleanroom/ Alvimedica Has Europe’s largest 10,000 Class Cleanroom]
  • Turkish success in stents features in Sweden’s most important business newspaper.{{Dead link|date=October 2018 |bot=InternetArchiveBot |fix-attempted=yes }}
  • Frizon föder ett helt nytt Turkiet

4 : Manufacturing companies based in Istanbul|Turkish companies established in 2007|Health care companies of Turkey|2007 establishments in Turkey

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/11/14 17:06:31